Polymorphism of racemic felodipine and the unusual series of solid solutions in the binary system of its enantiomers

Journal of Pharmaceutical Sciences

Volumn 90, Issue 7, 2001, Pages 949-959

  Rollinger, Judith M ^a   Burger, Artur ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Dihydropyridine; Enantiomers; Phase diagram; Polymorphism; Pseudoracemate; Solid solutions; Thermal analysis

Indexed keywords

FELODIPINE; SOLVENT;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; ENANTIOMER; FOURIER ANALYSIS; RACEMIC MIXTURE; RAMAN SPECTROMETRY; SOLID; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 0034942279     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.1046     Document Type: Article

References (29)

1. Calciumantagonisten vom dihydropyridintyp: Medizinisch - Chemische und molekularpharmakologische eigenschaften
2. Investigation of felodipine polymorphism and its glassy state
3. Polymorphism and pseudopolymorphism of nifedipine
4. Polymorphism in binary mixtures, as exemplified by nimodipine
5. Beitrag zur polymorphie von arzneistoffen 2. Mitteilung: Halofenat, lorcainidhydrochlorid, minoxidil, modipamol und nitrendipin
6. Binary system of (R)- and (S)-nitrendipine - Polymorphism and structure
7. Polymorphie pharmazeutischer wirkstoffe. Eine wirtschaftliche herausforderung?
8. Pharmaceutical solids: A strategic approach to regulatory considerations
9. Determination of the conformation of felodipine by 1H NMR spin-lattice relaxation time measurements
10. Synthesis of unsymmetrically substituted 1,4-dihydropyridines and analogous calcium antagonists by microwave heating
11. An improved synthesis of high purity felodipine
12. Synthesis of the enantiomers of felodipine and determination of their absolute configuration
13. Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: Concentration-effect relationships of racemic drugs and enantiomers
14. Crystal structure of the dihydropyridine Ca-antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data
15. Conformational polymorphism VI: The crystal and molecular structures of form II, III and V of 4-amino-N-2-pyridinylbenzenesulfonamide (sulfapyridine)
16. On the polymorphism of pharmaceuticals and other molecular crystals. I: Theory of thermodynamic rules
17. Advances in pharmaceutical materials and processing
18. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies
19. Beitrag zur thermischen analyse und zur polymorphie optischer antipoden: L-hyoscyamin - Atropin
20. Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propanolol
21. Fundamentals and predictions of resolution of enantiomer mixtures by crystallization in the example of phase diagrams of atenolol and atenolol hydrochloride salt
22. Löslichkeit und schmelzpunkt als kriterien für racemische verbindungen, pseudoracemische mischkrystalle und inaktive konglomerate
23. Molekülverbindungen, mischkristallbildung und neue polymorphiefälle bei barbituraten. I
24. Isomorphie und polymorphie bei barbitursäurederivaten
25. Binäre systeme von enantiomeren kawa-laktonen